Neurocore was founded in 2004 and through their Brain Performance Center they focus on providing brain-based training programs and assessments in order to help both children and adults improve their sleep, concentration, and to manage stress. Neurocore has been helping improve mental acuity, as well as treat mental disorders such as depression, ADHD, ASD, and anxiety, by applying the knowledge resulted from advances in brain mapping, neurofeedback, and EEG technology.
The National Institute of Mental Health notes that in 2016, there were 10.3 million adults in the United States who suffered from clinical depression. Episodes of clinical depression can last from weeks to years, and the exact causes for it are not known entirely. Many factors, such as genetics, hormones and brain chemistry can play a role in the illness.
Psychotherapy and antidepressants are the usual treatments for depression, but researchers and doctors have been treating the disorder using Neurotherapy for close to a decade, using EEG for diagnosis. In 1936, the first link between depression and EEG results has been published by Frederick Lemere. As a result of his studies, increased alpha activity is considered to be among the best indicators for depression.
Neurocore’s clinicians and scientists now use Lemere’s findings in order to offer a program that uses neurofeedback to train patients’ brain to overcome the symptoms of depression, and in some cases to overcome depression altogether. The program titled Medication-Free Depression Treatment Program uses qEEG mapping for assessment, as well as other diagnostic measures that help generate an accurate landscape of the patient’s depression symptoms. 292 clients completed the program offered by Neurocore, and 84% have experienced a noticeable diminish of their symptoms, while 51% are no longer meeting the symptomatic threshold for depression.
With over 14 years of experience, Neurocore became national authority in regards to applications of neuroscience. They have 8 brain performance centers open to the public in Michigan and in Florida. The company is making fast advancement in treating ADHD as well, in adults, teens and children. Out of thousands a children, an impressive 53% no longer meet the symptomatic threshold of the disorder, while 85% have experienced a noticeable reduction.
To Read More Click Here